Status:
UNKNOWN
Safety and Efficacy of BMMNCin Patients With Mental Retardation
Lead Sponsor:
Chaitanya Hospital, Pune
Conditions:
Mental Retardation
Eligibility:
All Genders
5-50 years
Phase:
PHASE1
PHASE2
Brief Summary
Mental retardation is a condition diagnosed before age 18 that includes below-average general intellectual function, and a lack of the skills necessary for daily living. Mental retardation affects abo...
Eligibility Criteria
Inclusion
- Age limit: 5 -50
- Primary diagnosis of mental retardation (IQ \< 70)
- willingness to undergo Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs) transplantation.
- To give an informed consent as well as sign the required Informed Consent Form (ICF)/video Consent for the study.
- willingness to regularly visit the hospital / clinic for follow up during the follow up period / on prior agreed time points as per the protocol.
Exclusion
- Positive test results for HIV and AIDS complex ,HCV (hepatitis C virus ), HbsAg and Syphilis
- Advanced age that may produce deteriorating cognitive or motor functioning
- Multiple sensory or motor disabilities that will interfere with seeing the stimuli and responding to the computer
- Poor general health
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01908400
Start Date
September 1 2014
End Date
November 1 2016
Last Update
September 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaitanya Hospital
Pune, Maharashtra, India, 411030